Canada markets closed

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.4400-0.1300 (-5.06%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5112.49M
Enterprise Value 369.43M
Trailing P/E N/A
Forward P/E 1-3.13
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.76
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.68

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3-78.95%
S&P500 52-Week Change 310.95%
52 Week High 313.5800
52 Week Low 31.9600
50-Day Moving Average 32.4703
200-Day Moving Average 32.7163

Share Statistics

Avg Vol (3 month) 3223.91k
Avg Vol (10 day) 3159.96k
Shares Outstanding 546.1M
Float 19.7M
% Held by Insiders 129.86%
% Held by Institutions 158.09%
Shares Short (Aug. 30, 2020) 41.66M
Short Ratio (Aug. 30, 2020) 49.26
Short % of Float (Aug. 30, 2020) 46.75%
Short % of Shares Outstanding (Aug. 30, 2020) 43.59%
Shares Short (prior month Jul. 30, 2020) 42.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-85.84%
Return on Equity (ttm)-182.24%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -102.01M
Net Income Avi to Common (ttm)-106.8M
Diluted EPS (ttm)-2.2750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.44M
Total Cash Per Share (mrq)0.88
Total Debt (mrq)6.14M
Total Debt/Equity (mrq)15.09
Current Ratio (mrq)3.31
Book Value Per Share (mrq)0.88

Cash Flow Statement

Operating Cash Flow (ttm)-82.83M
Levered Free Cash Flow (ttm)-44.13M